Dear Dr. Jesse,
We are looking back on a fruitful first meeting of European accreditors in Berlin.
This has been a very encouraging start to fulfill our mission statement, and we have enjoyed
high ranking representations from Austria, Bulgaria, Czech Republic, Germany, Ireland, and
the Netherlands. Participants appreciated that, for the first time European national
organizations involved in CME accreditation, had an opportunity to meet, exchange and
explore lines of consensus as well as areas of interest for future collaboration.We should now
look for strategies to enlarge the group, and identify opportunities for future cooperation of
accreditors. Outcomes have been summarized in the paper attached.
Results of this meeting have been reported in a workshop on perspectives of cooperation of
accreditors at the European CME Forum in London last week.
In the hope that you will also join as co-authors of the position paper we remain with
Best regards
Fabiola de Andrade Prof. Reinhard Griebenow
Am 22.10.2018 um 12:43 schrieb CME-EA <
[email protected]>:
Dear Dr. Jesse,
Please find attached the agenda for the meeting mentioned below. We would
very much appreciate, if you could indicate in advacnce, who is going to
participate on behalf of your organization.
See you in Berlin and best regards
Fabiola de Andrade Prof. Reinhard Griebenow,MD
Chair, CME-EA Vice-chair, CME-EA
<Agenda- Berlin meeting.pdf>
Am 16.10.2018 um 10:27 schrieb CME-EA <
[email protected]>:
Dear Dr. Jesse,
This is a kind reminder on the Berlin consensus meeting taking
place on
October 31st, 2018, 11am-4pm
Bundesärztekammer
Herbert–Lewin-Platz 1
10623 Berlin
(near S-train station “Tiergarten”)
Several national accreditors have already committed to engage in this
process, thus contributing to a movement of the medical profession in
Europe demonstrating, that we all follow the same set of principles in CME-
CPD, including independence of information as dominant requirement.
Looking forward to meeting you in Berlin we remain
With best regards
Fabiola de Andrade Prof. Reinhard
Griebenow,MD
Chair, CME-EA Vice-chair, CME-
EA
P.S. Please note: cost for travel and accommodation have to be
covered by your organisation, a buffet lunch will be provided.
For planning purposes we kindly ask you to let us know in
advance how many members of your organisation are going to
attend.
Am 18.09.2018 um 20:41 schrieb CME-EA
<
[email protected]>:
Dear Dr. Jesse,
recent activities from industry to become
recognised as providers in accredited CME-CPD
need a joint response from European
organisations involved in accreditation of CME-
CPD on the national as well as international
level. CME-EA has started to facilitate and
moderate this process by preparing a draft
position paper, and would like to invite your
organisation to contribute as co-author to the
final version, to be published in national as well
as international media (please see attachments to
this invitation).
Thus, on behalf of CME-EA we would like to
invite you to a live meeting to take place at the
premises of the German Medical Association on
October 31st, 2018, 11am-4pm
Bundesärztekammer
Herbert–Lewin-Platz 1
10623 Berlin
(near S-train station “Tiergarten”)
The invitation primarily reaches out to
accreditation bodies. In case that CME
accreditation has not been implemented on the
national level, organisations in charge of
defining professional standards have been
invited. If this should not relate to your
organisation, we would be grateful, if you could
pass the invitation to those in charge or most
interested in this matter.
Looking forward to meet you in Berlin we
remain
With best regards
Fabiola de Andrade Prof.
Reinhard Griebenow,MD
Chair, CME-EA Vice-
chair, CME-EA
P.S. Please note: cost for travel and
accommodation have to be covered by your
organisation, a buffet lunch will be provided. For
planning purposes we kindly ask you to let us
know in advance how many members of your
organisation are going to attend.
<AnfahrtskizzeBAEK2010Gross.jpg>
<Framework for industry engagement and
quality principles for industry provided medical
education in Europe.pdf>
<Cover letter- position paper-f.pdf>
<Position Paper on Accreditation of CME-CPD
and Independence-f.docx>
Position paper
Independent Continuing Medical Education
(CME)/Continuing Professional Development (CPD) means at
first independent information
Authors: European accreditation bodies
(national/international)
Physicians have committed themselves to always act in the best interest of their patients
(1), this includes their approach to continuing medical education (CME) as well as
continuing professional development (CPD) which are cornerstones for the maintenance
of professional competence (MOC). For many years professional codes, and in some
countries also the (professional) law, have defined that CME/CPD must be independent
of commercial interests (1, EU-national).
Over the last few decades numerous national bodies have introduced CME/CPD
accreditation to ensure that the planning and conduct of CME/CPD follows a set of
defined standards, with independence of commercial interests as one of the leading
principles (EU-national, 2, 3).
In Europe, this is augmented by an additional type of accreditor, the European
international accreditor. These accreditors include members of CME-EA, EACCME and
other organisations and are devoted to accreditation of CME/CPD activities in Europe
that have primarily international attendance.
However, accreditation has little value in and on its own, it is almost entirely dependent
on having clear and transparent definitions, rigorous application of appropriate
principles and rules, and being in the position to enforce its own standards.
With regard to enforcement , only a few European national accreditation systems are
officially legitimated by national jurisdictions (e.g. DE, AT, IT). This enables the
accreditor to impose accreditation on all providers nationwide (but vice-versa also
imposing legal liability on the accreditor).
But still many accreditors in Europe (including all European international accreditors)
are institutions based on civil law, and thus lack official legitimation.
Despite the sometimes uncertain legal basis CME/CPD accreditation still serves as an
important component of quality assurance in medicine. Accreditation safeguards the
credibility of the medical profession in one of the most important areas in medicine, i.e.
maintenance of our intellectual basis in medical decision-making by life-long learning.
Thus, irrespective of the variable legal status, accreditors will only be able to convince
the (medical) public, and prove their legitimacy by comprehensible and rigorous
application of their transparent principles and rules.
All major accreditation systems grant accreditation prior to the start of the CME/CPD
activity. This implies that accreditation relies on professional honesty, and self-
commitment of the medical professionals involved in delivery of CME/CPD, to align their
presentations with the principles and rules as outlined by the accreditor.
There are several key principles in medical education to be followed by providers
(which should also be used by participants to evaluate a given CME/CPD activity):
It all starts with independence of information itself as well as independence of
interpretation of information in the appropriate clinical context. Other criteria like
educational efficacy of a CME/CPD activity are of secondary importance in light of the
fundamental bias introduced by use of framed information in life-long learning.
Fully transparent and timely provision of data can obviously collide with the commercial
interests of industry (4, 5, 6), as driven by the market economy’s framework set by
governments in most developed countries. This limitation weighs even more in the light
of the fact that currently about 80% of all trial patients are in clinical trials sponsored by
industry (7).
Whilst the development and provision of drugs and devices continues to follow the
fundamental principles of a market economy with its inbuilt difficulties of accessing
information, then if we were to accept industry as a provider of accredited CME/CPD, as
recently proposed in the Journal (8), then we would open the door for the introduction
of an inevitable bias in CME/CPD. It is for this reason that major accreditors have
recently reiterated in a global consensus document that “the content, as well as persons
and organizations in control of the content, of the accredited CME/CPD activity is
developed/selected independently, with no influence, control or involvement from a
commercial interest...” (9).
Many accreditors go one step further by defining the details of communication to
participants to avoid any misperceptions with regard to promotion (10, EU-national), in
particular in sponsored CME/CPD.
Accreditors are well aware that in CME/CPD there are further threats to independent
alignment of evidence with current strategies in diagnosis and treatment of particular
conditions (interpretation), and discussion on how to apply evidence in the individual
patient (implementation):
- This includes a long list of (potential conflicts of) interests, including issues
related to career development and/or welfare of individuals involved in planning
and delivery of CME, but also institutional interests e.g. of hospital owners,
insurance companies etc. Thus, fully transparent communication of interests to
participants in CME/CPD as well as management of the conflicts of interest are
indispensable supportive strategies in planning and delivery of independent
CME/CPD, but they can never outweigh the negative effects of information
compromised by commercial interests. This also applies to the principles of
evidence based medicine, whose practice has been further facilitated by
development of elaborate methods for post-processing of information to design
tools to support clinical decision-making by recommendations based on grading
of the strength of evidence (11), or by provision of systematic reviews and meta-
analyses (12). Major accreditors recommend the systematic use of these tools in
the provision of accredited CME/CPD (EU-national, -international). However, the
value of such tools also critically depends on timely and complete availability of
data to obtain a realistic estimate of benefit-risk ratios of diagnostic and/or
therapeutic interventions.
- CME/CPD should always be designed to help participants to close gaps in
knowledge and/or professional performance. The underlying gap analysis as well
as definition of “learning objectives” mark another area, in which commercial
interests should never be involved to avoid direct agenda setting by industry,
although accreditors are well aware that indirect agenda setting currently occurs
by allocation of sponsoring: Evidence is available that CME with industry
involvement has a narrower range of topics and more product-related content
than CME without direct industry involvement even when funding is unrestricted
(13).
The primary importance of independence in accreditation should not override the
consideration of the role of different educational formats for the delivery of effective
CME/CPD. Although overall educational quality may be considered as satisfactory (EU-
national, -international), accreditors have always wanted to stimulate improvement, as
demonstrated by initiatives to stimulate providers to further develop their educational
formats (EU-national, -international).
CME/CPD accreditation has been designed to mark the difference between independent,
strictly evidence based CME/CPD and interest driven CME/CPD. If there were to be no
differences in requirements for independence any more, accreditation alone will not be
able to resolve the issue and may be seen as no longer needed.
In certain jurisdictions (Germany, 14) commercially driven CME/CPD may also be
considered as providing inadequate independence in influencing opinion formation, and
decision-making. This mixing up of CME/CPD with commercial interests may introduce
further difficulties with differentiating medical education from advertising.
Accreditation of CME/CPD currently serves several different purposes, but its fate will
be decided by whether it can retain its ability to differentiate independent CME/CPD
from provision of commercially framed information.
References
1. World Medical Association Declaration of Geneva,
accessed on Jan. 18th, 2018: https://www.wma.net/policies-post/wma-
declaration-of-geneva/
2. ACCME Standards for Commercial Support: Standards to Ensure Independence in
CME Activities
Accessed on Jan. 18th, 2018: http://www.accme.org/requirements/accreditation-
requirements-cme-providers/standards-for-commercial-support
3. National Standard for Support of Accredited CPD Activities
Accessed on Jan. 18th, 2018:
http://www.royalcollege.ca/rcsite/cpd/providers/tools-resources-accredited-
cpd-providers/national-standard-accredited-cpd-activities-e
4. Köhler M, Haag S, Biester K, et al. Information on new drugs at market entry:
retrospective analysis of health technology assessment reports versus regulatory
reports, journal publications, and registry reports. Bmj. 2015;350:h796.
5. Anderson ML, Chiswell K, Peterson ED, et al. Compliance with results reporting at
clinical trials.gov. N Engl J Med. 2015;372:1031–1039.
6. European Medicines Agency: Clinical Trial Regulation
Accessed on Jan. 18th, 2018:
http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/gene
ral_content_000629.jsp
7. Flacco ME, Manzoli L, Boccia S, et al. Head-to-head rando- mized trials are mostly
industry sponsored and almost always favor the industry sponsor. J Clin
Epidemiology. 2015;68:811–820.
8. Tamara Allen, Nina Donde, Eva Hofstädter-Thalmann, Sandra Keijser, Veronique
Moy, Jean-Jacques Murama & Thomas Kellner (2017) Framework for industry
engagement and quality principles for industry-provided medical education in
Europe, Journal of European CME, 6:1, 1348876, DOI:
10.1080/21614083.2017.1348876
9. International Academy for CPD Accreditation:
Consensus Statement for Independence and Funding of Continuing Medical
Education (CME)/ Continuing Professional Development
Accessed on Jan. 18th, 2018:
https://academy4cpdaccreditation.files.wordpress.com/2018/01/consensus-
statement-for-independence-and-funding-of-cme_cpd_final.pdf
10. Daiana Stolz, Reinhard Griebenow, Andre Tichelli, Andrew J. Ullmann, Richard
Costello, Lampros Michalis, Margarita Guenova, Sandy Sutter, Fabiola De Andrade
& Robert Schaefer (2017) Position paper on current aspects of sponsoring in
accredited CME, Journal of European CME, 6:1, 1312062, DOI:
10.1080/21614083.2017.1312062
11. The Grading of Recommendations Assessment, Development and Evaluation
(GRADE) working group
Accessed on Jan. 18th, 2018: http://www.gradeworkinggroup.org
12. Cochrane Library
Accessed on Jan. 18th, 2018: http://www.cochranelibrary.com
13. Katz HP, Goldfinger SE, Fletcher SW. Academia-industry collaboration in
continuing medical education: description of two approaches. J Contin Educ
Health Prof. 2002;22(1):43–54.
14. Gesetz zur Bekämpfung von Korruption im Gesundheitswesen (Law against
corruption in the health-care system)
Accessed on Jan. 18th, 2018:
https://www.bmjv.de/SharedDocs/Gesetzgebungsverfahren/Dokumente/BGBl_
Bekaempfung_Korruption_Gesundheitswesen.pdf?__blob=publicationFile&v=3
European Accreditors’ Consensus Meeting
Oct. 31st, 2018, Berlin
1. Position paper on independence of CME-CPD:
• Participants expressed no wish for revision; paper will now be submitted
to relevant national bodies for approval by end of Q1 2019 latest
• Relevant national documents to be quoted in the paper will be sent to
CME-EA for alignment of the references list. Please just mark, where
you would like to see it being inserted.
• Authors: institutions, aligned in alphabetical order in English language
• Outcome, as described above, will be reported in a workshop on
perspectives of cooperation of accreditors at the European CME Forum,
Nov. 7-9, 2018, in London, and to Robin Stevenson, editor-in-chief
Journal of European CME (JECME).
• Participants support the idea to give those not able to make the live
meeting the opportunity to embark as co-authors until end of Q1 2019.
• Manuscript will be submitted to JECME, and disseminated via the
relevant national media, too.
2. Exchange of documents relevant to CME accreditation on the
national level:
• Participants will hand in their documents relevant to CME accreditation
in their country to CME-EA for distribution in the group (in English
language).
• CME-EA offers to establish links from the CME-EA website to the
relevant sections of the websites of national organisations for access to
national documents relevant to CME accreditation.
3. Miscellaneous:
• Consider membership in International Academy for CPD Accreditation
(membership criteria on International Academy website,
www.academy4cpd-accreditation.org, membership is informal and free
of charge)
• Cologne Consensus Conference (CCC) 2019 (Sept. 13-14) has been
chosen by International Academy as yearly live meeting
• Call to contribute to CCC 2019 on “Standards and Guidelines in
Accredited CPD”
• Identification of areas of interest for future projects of collaboration:
• Explore opportunities to join forces in evaluation, to generate data on
specially targeted, temporary assessment of effectivity of CME.
• Discuss concept and practice of substantial equivalency of accreditors
• Further ideas welcome!
Tentative date for next meeting: spring 2019